Quimioterapia


Administering Rituxan in R-CHOP
Aprepitant (Emend®) for Ablative Regimens
Arimidex and Insomnia
Arthritis and Chemotherapy
Avastin Before or After Chemotherapy
BCG Therapy Safety
BCG Therapy Safety
Birth Defects While on Chemotherapy
Chemo-Brain
Chemotherapy and diabetic patients
Chemotherapy and osteoporosis
Chemotherapy Exposure During Pregnancy
Clean House while on Cancer Treatment
Coloring Hair After Chemotherapy
Combretastatin
Combretastatin Clinical Trials
CPT-11 (Irinotecan) and Radiation Side Effects
Crushing Chemotherapy Pills
Dihydropyrimidine dehydrogenase (DPD) Deficiency
Does chemotherapy make you toxic?
Dose Dense Chemotherapy for Lymphoma
ESHAP Regimen
Exposure to Children While Having Cancer Treatment
Exposure to environmental tobacco smoke during chemotherapy
Fertility During Chemotherapy
Flu Shots While on Chemotherapy
Hand Foot Syndrome
Heart Damage and Chemotherapy
Hypoglycemia on AIs
Improving white blood cell count during chemotherapy
Is grapefruit contraindicated during chemotherapy?
Leucovorin
Long-Term Effects of Chemotherapy and Radiation Treatments
Losing Fingernails After Chemotherapy
Male Sterility from Gleevec
Medications that Interact with Tamoxifen
Metallic taste after chemotherapy
Number of Chemotherapy Cycles
ONJ and Dental Procedures
Order of Chemotherapy Administration
Predict Response to Chemotherapy?
Pregnancy While on Chemotherapy
Pregnant Women Exposure to People Undergoing Therapy
Rash related to Erbitux
Recurrent or metastatic melanoma treatment options
Reimmunization after Chemotherapy
Rituxan
Rituxan
Safe handling of bodily fluids after cancer therapy
Safe handling of bodily fluids after chemotherapy
Sexual Activity During Chemotherapy
Taking AIs Beyond 5 Years
Topical Chemotherapy Precautions
Topotecan
Treatment for Peripheral Neuropathy

News
Studies outline new options for the standard treatment of various lymphoma types

Dec 7, 2010 - Rituximab may be a better option than watchful waiting in some lymphoma patients, and a new treatment option appears effective for relapsed or refractory Hodgkin's lymphoma, according to two studies being presented at the annual meeting of the American Society of Hematology, held from Dec. 4 to 7 in Orlando, Fla. Other research being presented will highlight new options for the standard treatment of advanced asymptomatic follicular lymphoma; mantle cell lymphoma; and early, unfavorable Hodgkin's disease.



I Wish You Knew

Understanding prostate cancer screening

View More



Blogs and Web Chats

OncoLink Blogs give our readers a chance to react to and comment on key cancer news topics and provides a forum for OncoLink Experts and readers to share opinions and learn from each other.




OncoLink OncoPilot

Frente a un nuevo diagnóstico de cáncer o de cambiar el curso de su tratamiento actual? Deje que nuestro personal de enfermería cáncer que ayudan a pasar!

Más información